Lightstone Ventures
Lightstone Ventures, founded in 2012, is a venture capital firm dedicated to empowering visionary founders to bring innovative therapeutics to patients in need. The firm focuses on funding novel, disruptive technologies in the biotech and medtech industries to transform patients' lives. With a global reach and offices in the U.S. and Ireland, Lightstone Ventures partners with companies to navigate their growth from start-up to commercialization, providing strategic guidance and patient capital.
Lightstone Ventures
LSV Capital Management, LLC. 3270 Alpine Road Portola Valley, CA 94028
What We Do
Lightstone Ventures partners with portfolio companies to provide strategic guidance and mentorship, helping them navigate day-to-day functions and establish strategies to transform their vision into commercially viable products.
The firm provides financial backing to its portfolio companies, investing with a long-term vision and patient capital to support companies through their life cycle from start-up to commercialization.
With offices in the U.S. and Ireland, Lightstone Ventures builds a network with non-U.S. strategic and financial funding sources, exploring novel development and commercialization strategies in these geographies.
Geographic Focus
Industry Focus
Show More (3)Portfolio
Acceleron Pharma is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. The company successfully completed an IPO in 2013.
#Biopharmaceuticals
Alchemab Therapeutics is using deep learning and cutting-edge science to develop novel drugs for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies and the adaptive immune system.
#Biopharmaceuticals
Allay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation for patients and physicians.
#Biopharmaceuticals
ALX Oncology is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism, which is exploited by cancer cells to evade the immune system. The company successfully completed an IPO in 2020 (NASDAQ: ALXO).
#Biopharmaceuticals
Amber Therapeutics was founded in 2021 with a mission to develop an adaptive neuromodulation therapy that aims to be the first and only singular therapy able to treat mixed urinary incontinence (UUI and SUI).
#Medical Technology
Apreo Health is a development stage medical technology company that is developing innovative, globally applicable treatments for pulmonary disease.
#Medical Technology
Key People
Managing Partner
Managing Partner
Founding Partner
Partner
Partner
Partner